Stereoselective transport of human His27- and Arg27-reduced folate carrier

Tomoya Narawa1, Hideaki Yanagisawa, Tomoo Itoh

  • 1School of Pharmacy, Kitasato University.

Insights

The human reduced folate carrier (hRFC) transports methotrexate enantiomers stereoselectively. Differences in binding affinity explain the differential uptake of L-methotrexate and D-methotrexate by hRFC.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Methotrexate (MTX) is a crucial antifolate drug used in chemotherapy.
  • Understanding the transport mechanisms of MTX enantiomers is vital for optimizing drug efficacy.
  • The human reduced folate carrier (hRFC) plays a significant role in cellular folate uptake.

Purpose of the Study:

  • To investigate the stereoselective transport of L-methotrexate (L-MTX) and D-methotrexate (D-MTX) by hRFC.
  • To characterize the kinetic parameters and pH dependency of hRFC-mediated MTX enantiomer transport.
  • To determine the inhibitory effects of MTX enantiomers on each other's transport.

Main Methods:

  • HEK293 cells expressing specific hRFC variants (H27-hRFC and R27-hRFC) were utilized.
  • Uptake assays were performed at varying extracellular pH levels (6.0 to 7.4).
  • Kinetic analysis (Michaelis-Menten, Dixon plots) and competitive inhibition studies were conducted.

Main Results:

  • Extracellular pH significantly influenced the uptake of both L-MTX and D-MTX.
  • hRFC-mediated uptake of L-MTX followed Michaelis-Menten kinetics with distinct Km values for H27- and R27-hRFC variants.
  • D-MTX competitively inhibited L-MTX uptake, indicating shared binding sites but with lower affinity compared to L-MTX.

Conclusions:

  • hRFC exhibits stereoselective transport for methotrexate enantiomers.
  • Significant differences in the affinities of L-MTX and D-MTX to hRFC underlie this stereoselectivity.
  • These findings provide insights into the molecular basis of folate carrier function and MTX pharmacokinetics.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.6K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
189
Facilitated Diffusion01:16

Facilitated Diffusion

The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
1.7K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
5.7K
The Significance of Membrane Transport01:44

The Significance of Membrane Transport

The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
24.3K
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
388